Cargando…
Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers
PURPOSE: Vasomotor symptoms (VMS) such as hot flashes and night sweats are common in breast cancer patients and can affect both quality of life and treatment adherence. However, there is limited practical data to guide clinicians in the optimal selection of therapeutic strategies. A survey of health...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219176/ https://www.ncbi.nlm.nih.gov/pubmed/34159473 http://dx.doi.org/10.1007/s10549-021-06186-8 |
_version_ | 1783710879902072832 |
---|---|
author | Cole, Katherine Marie Clemons, Mark Alzahrani, Meshari Larocque, Gail MacDonald, Fiona Vandermeer, Lisa Hutton, Brian Piper, Ardelle Pond, Greg McGee, Sharon |
author_facet | Cole, Katherine Marie Clemons, Mark Alzahrani, Meshari Larocque, Gail MacDonald, Fiona Vandermeer, Lisa Hutton, Brian Piper, Ardelle Pond, Greg McGee, Sharon |
author_sort | Cole, Katherine Marie |
collection | PubMed |
description | PURPOSE: Vasomotor symptoms (VMS) such as hot flashes and night sweats are common in breast cancer patients and can affect both quality of life and treatment adherence. However, there is limited practical data to guide clinicians in the optimal selection of therapeutic strategies. A survey of health care providers was performed to better understand perspectives and prescribing practices for managing this problem. METHODS: Canadian health care providers who treat patients with early stage breast cancer (EBC) participated in an anonymous electronic survey. Participants provided their perspectives on the prevalence and severity of VMS among patients with EBC, outlined their management strategies, and provided feedback on the perceived efficacy of interventions for VMS. RESULTS: Responses were received from 65 providers including breast oncologists (36/65, 55%) and nurses with oncology expertise (29/65, 45%). Seventy-seven percent of participants reported regularly asking patients about VMS, and most indicated that bothersome VMS occurred in the majority of patients. Health care providers cited hot flash severity and sleep disruption as the most important issues for patients. The most common first- and second-line interventions recommended were lifestyle modifications (n = 32/65, 49.2%) and pharmacologic strategies (n = 27/65, 41.5%), respectively. Most respondents felt that interventions, including pharmacologic, over-the-counter, and complementary therapies, were only “somewhat effective”. Overall, half of respondents (n = 35/65, 54%) reported being “confident” in managing VMS. CONCLUSION: Given the variability of treatment recommendations, and health care provider uncertainty around the benefits of therapies for VMS, more ‘real-world’ trials are needed to optimize patient care. |
format | Online Article Text |
id | pubmed-8219176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82191762021-06-23 Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers Cole, Katherine Marie Clemons, Mark Alzahrani, Meshari Larocque, Gail MacDonald, Fiona Vandermeer, Lisa Hutton, Brian Piper, Ardelle Pond, Greg McGee, Sharon Breast Cancer Res Treat Clinical Trial PURPOSE: Vasomotor symptoms (VMS) such as hot flashes and night sweats are common in breast cancer patients and can affect both quality of life and treatment adherence. However, there is limited practical data to guide clinicians in the optimal selection of therapeutic strategies. A survey of health care providers was performed to better understand perspectives and prescribing practices for managing this problem. METHODS: Canadian health care providers who treat patients with early stage breast cancer (EBC) participated in an anonymous electronic survey. Participants provided their perspectives on the prevalence and severity of VMS among patients with EBC, outlined their management strategies, and provided feedback on the perceived efficacy of interventions for VMS. RESULTS: Responses were received from 65 providers including breast oncologists (36/65, 55%) and nurses with oncology expertise (29/65, 45%). Seventy-seven percent of participants reported regularly asking patients about VMS, and most indicated that bothersome VMS occurred in the majority of patients. Health care providers cited hot flash severity and sleep disruption as the most important issues for patients. The most common first- and second-line interventions recommended were lifestyle modifications (n = 32/65, 49.2%) and pharmacologic strategies (n = 27/65, 41.5%), respectively. Most respondents felt that interventions, including pharmacologic, over-the-counter, and complementary therapies, were only “somewhat effective”. Overall, half of respondents (n = 35/65, 54%) reported being “confident” in managing VMS. CONCLUSION: Given the variability of treatment recommendations, and health care provider uncertainty around the benefits of therapies for VMS, more ‘real-world’ trials are needed to optimize patient care. Springer US 2021-06-22 2021 /pmc/articles/PMC8219176/ /pubmed/34159473 http://dx.doi.org/10.1007/s10549-021-06186-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Clinical Trial Cole, Katherine Marie Clemons, Mark Alzahrani, Meshari Larocque, Gail MacDonald, Fiona Vandermeer, Lisa Hutton, Brian Piper, Ardelle Pond, Greg McGee, Sharon Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title | Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title_full | Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title_fullStr | Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title_full_unstemmed | Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title_short | Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
title_sort | developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers |
topic | Clinical Trial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219176/ https://www.ncbi.nlm.nih.gov/pubmed/34159473 http://dx.doi.org/10.1007/s10549-021-06186-8 |
work_keys_str_mv | AT colekatherinemarie developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT clemonsmark developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT alzahranimeshari developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT larocquegail developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT macdonaldfiona developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT vandermeerlisa developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT huttonbrian developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT piperardelle developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT pondgreg developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders AT mcgeesharon developingpatientcentredstrategiestooptimizethemanagementofvasomotorsymptomsinbreastcancerpatientsasurveyofhealthcareproviders |